Therapeutic management of peritonitis: a comprehensive guide for intensivists.
Identifieur interne : 001B26 ( PubMed/Curation ); précédent : 001B25; suivant : 001B27Therapeutic management of peritonitis: a comprehensive guide for intensivists.
Auteurs : P. Montravers [France] ; S. Blot [Belgique] ; G. Dimopoulos [Grèce] ; C. Eckmann [Allemagne] ; P. Eggimann [Suisse] ; X. Guirao [Espagne] ; J A Paiva [Portugal] ; G. Sganga [Italie] ; J. De Waele [Belgique]Source :
- Intensive care medicine [ 1432-1238 ] ; 2016.
Descripteurs français
- KwdFr :
- MESH :
- normes : Antibactériens, Soins de réanimation.
- traitement médicamenteux : Péritonite.
- usage thérapeutique : Antibactériens.
- Adulte, Adulte d'âge moyen, Femelle, Guides de bonnes pratiques cliniques comme sujet, Humains, Maladie grave, Mâle, Sujet âgé, Sujet âgé de 80 ans ou plus.
English descriptors
- KwdEn :
- MESH :
- chemical , standards : Anti-Bacterial Agents.
- chemical , therapeutic use : Anti-Bacterial Agents.
- drug therapy : Peritonitis.
- standards : Critical Care.
- therapy : Critical Illness.
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Practice Guidelines as Topic.
Abstract
The management of peritonitis in critically ill patients is becoming increasingly complex due to their changing characteristics and the growing prevalence of multidrug-resistant (MDR) bacteria.
DOI: 10.1007/s00134-016-4307-6
PubMed: 26984317
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001B50
Links to Exploration step
pubmed:26984317Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Therapeutic management of peritonitis: a comprehensive guide for intensivists.</title><author><name sortKey="Montravers, P" sort="Montravers, P" uniqKey="Montravers P" first="P" last="Montravers">P. Montravers</name><affiliation wicri:level="1"><nlm:affiliation>APHP, CHU Bichat-Claude Bernard, Département d'Anesthésie Réanimation, Université Denis Diderot, PRESS Sorbonne Cité, Paris, France. philippe.montravers@aphp.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>APHP, CHU Bichat-Claude Bernard, Département d'Anesthésie Réanimation, Université Denis Diderot, PRESS Sorbonne Cité, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Blot, S" sort="Blot, S" uniqKey="Blot S" first="S" last="Blot">S. Blot</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Ghent University, Ghent, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Internal Medicine, Ghent University, Ghent</wicri:regionArea></affiliation></author><author><name sortKey="Dimopoulos, G" sort="Dimopoulos, G" uniqKey="Dimopoulos G" first="G" last="Dimopoulos">G. Dimopoulos</name><affiliation wicri:level="1"><nlm:affiliation>Department of Critical Care, University Hospital Attikon, Medical School, University of Athens, Athens, Greece.</nlm:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Critical Care, University Hospital Attikon, Medical School, University of Athens, Athens</wicri:regionArea></affiliation></author><author><name sortKey="Eckmann, C" sort="Eckmann, C" uniqKey="Eckmann C" first="C" last="Eckmann">C. Eckmann</name><affiliation wicri:level="1"><nlm:affiliation>Department of General, Visceral and Thoracic Surgery, Klinikum Peine, Peine, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of General, Visceral and Thoracic Surgery, Klinikum Peine, Peine</wicri:regionArea></affiliation></author><author><name sortKey="Eggimann, P" sort="Eggimann, P" uniqKey="Eggimann P" first="P" last="Eggimann">P. Eggimann</name><affiliation wicri:level="1"><nlm:affiliation>Department of Intensive Care Medicine and Burn Center, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Intensive Care Medicine and Burn Center, Centre Hospitalier Universitaire Vaudois, Lausanne</wicri:regionArea></affiliation></author><author><name sortKey="Guirao, X" sort="Guirao, X" uniqKey="Guirao X" first="X" last="Guirao">X. Guirao</name><affiliation wicri:level="1"><nlm:affiliation>Department of Endocrine and Head and Neck Surgery, Corporació Sanitaria del Parc Tauli, University Hospital, Sabadell, Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Endocrine and Head and Neck Surgery, Corporació Sanitaria del Parc Tauli, University Hospital, Sabadell, Barcelona</wicri:regionArea></affiliation></author><author><name sortKey="Paiva, J A" sort="Paiva, J A" uniqKey="Paiva J" first="J A" last="Paiva">J A Paiva</name><affiliation wicri:level="1"><nlm:affiliation>Emergency and Intensive Care Department, Centro Hospitalar S. João EPE, Porto, Portugal.</nlm:affiliation><country xml:lang="fr">Portugal</country><wicri:regionArea>Emergency and Intensive Care Department, Centro Hospitalar S. João EPE, Porto</wicri:regionArea></affiliation></author><author><name sortKey="Sganga, G" sort="Sganga, G" uniqKey="Sganga G" first="G" last="Sganga">G. Sganga</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Catholic University of Sacred Heart, Policlinico A Gemelli, Rome, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Surgery, Catholic University of Sacred Heart, Policlinico A Gemelli, Rome</wicri:regionArea></affiliation></author><author><name sortKey="De Waele, J" sort="De Waele, J" uniqKey="De Waele J" first="J" last="De Waele">J. De Waele</name><affiliation wicri:level="1"><nlm:affiliation>Department of Critical Care Medicine, Ghent University Hospital, Ghent, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Critical Care Medicine, Ghent University Hospital, Ghent</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26984317</idno><idno type="pmid">26984317</idno><idno type="doi">10.1007/s00134-016-4307-6</idno><idno type="wicri:Area/PubMed/Corpus">001B50</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B50</idno><idno type="wicri:Area/PubMed/Curation">001B26</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001B26</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Therapeutic management of peritonitis: a comprehensive guide for intensivists.</title><author><name sortKey="Montravers, P" sort="Montravers, P" uniqKey="Montravers P" first="P" last="Montravers">P. Montravers</name><affiliation wicri:level="1"><nlm:affiliation>APHP, CHU Bichat-Claude Bernard, Département d'Anesthésie Réanimation, Université Denis Diderot, PRESS Sorbonne Cité, Paris, France. philippe.montravers@aphp.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>APHP, CHU Bichat-Claude Bernard, Département d'Anesthésie Réanimation, Université Denis Diderot, PRESS Sorbonne Cité, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Blot, S" sort="Blot, S" uniqKey="Blot S" first="S" last="Blot">S. Blot</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Ghent University, Ghent, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Internal Medicine, Ghent University, Ghent</wicri:regionArea></affiliation></author><author><name sortKey="Dimopoulos, G" sort="Dimopoulos, G" uniqKey="Dimopoulos G" first="G" last="Dimopoulos">G. Dimopoulos</name><affiliation wicri:level="1"><nlm:affiliation>Department of Critical Care, University Hospital Attikon, Medical School, University of Athens, Athens, Greece.</nlm:affiliation><country xml:lang="fr">Grèce</country><wicri:regionArea>Department of Critical Care, University Hospital Attikon, Medical School, University of Athens, Athens</wicri:regionArea></affiliation></author><author><name sortKey="Eckmann, C" sort="Eckmann, C" uniqKey="Eckmann C" first="C" last="Eckmann">C. Eckmann</name><affiliation wicri:level="1"><nlm:affiliation>Department of General, Visceral and Thoracic Surgery, Klinikum Peine, Peine, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of General, Visceral and Thoracic Surgery, Klinikum Peine, Peine</wicri:regionArea></affiliation></author><author><name sortKey="Eggimann, P" sort="Eggimann, P" uniqKey="Eggimann P" first="P" last="Eggimann">P. Eggimann</name><affiliation wicri:level="1"><nlm:affiliation>Department of Intensive Care Medicine and Burn Center, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Intensive Care Medicine and Burn Center, Centre Hospitalier Universitaire Vaudois, Lausanne</wicri:regionArea></affiliation></author><author><name sortKey="Guirao, X" sort="Guirao, X" uniqKey="Guirao X" first="X" last="Guirao">X. Guirao</name><affiliation wicri:level="1"><nlm:affiliation>Department of Endocrine and Head and Neck Surgery, Corporació Sanitaria del Parc Tauli, University Hospital, Sabadell, Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Endocrine and Head and Neck Surgery, Corporació Sanitaria del Parc Tauli, University Hospital, Sabadell, Barcelona</wicri:regionArea></affiliation></author><author><name sortKey="Paiva, J A" sort="Paiva, J A" uniqKey="Paiva J" first="J A" last="Paiva">J A Paiva</name><affiliation wicri:level="1"><nlm:affiliation>Emergency and Intensive Care Department, Centro Hospitalar S. João EPE, Porto, Portugal.</nlm:affiliation><country xml:lang="fr">Portugal</country><wicri:regionArea>Emergency and Intensive Care Department, Centro Hospitalar S. João EPE, Porto</wicri:regionArea></affiliation></author><author><name sortKey="Sganga, G" sort="Sganga, G" uniqKey="Sganga G" first="G" last="Sganga">G. Sganga</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Catholic University of Sacred Heart, Policlinico A Gemelli, Rome, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Surgery, Catholic University of Sacred Heart, Policlinico A Gemelli, Rome</wicri:regionArea></affiliation></author><author><name sortKey="De Waele, J" sort="De Waele, J" uniqKey="De Waele J" first="J" last="De Waele">J. De Waele</name><affiliation wicri:level="1"><nlm:affiliation>Department of Critical Care Medicine, Ghent University Hospital, Ghent, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Critical Care Medicine, Ghent University Hospital, Ghent</wicri:regionArea></affiliation></author></analytic><series><title level="j">Intensive care medicine</title><idno type="eISSN">1432-1238</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Anti-Bacterial Agents (standards)</term><term>Anti-Bacterial Agents (therapeutic use)</term><term>Critical Care (standards)</term><term>Critical Illness (therapy)</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Peritonitis (drug therapy)</term><term>Practice Guidelines as Topic</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Antibactériens (normes)</term><term>Antibactériens (usage thérapeutique)</term><term>Femelle</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Maladie grave ()</term><term>Mâle</term><term>Péritonite (traitement médicamenteux)</term><term>Soins de réanimation (normes)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term></keywords><keywords scheme="MESH" type="chemical" qualifier="standards" xml:lang="en"><term>Anti-Bacterial Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Peritonitis</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Antibactériens</term><term>Soins de réanimation</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Critical Care</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Critical Illness</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Péritonite</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Practice Guidelines as Topic</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Maladie grave</term><term>Mâle</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The management of peritonitis in critically ill patients is becoming increasingly complex due to their changing characteristics and the growing prevalence of multidrug-resistant (MDR) bacteria.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26984317</PMID><DateCreated><Year>2016</Year><Month>07</Month><Day>02</Day></DateCreated><DateCompleted><Year>2017</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2017</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>8</Issue><PubDate><Year>2016</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Therapeutic management of peritonitis: a comprehensive guide for intensivists.</ArticleTitle><Pagination><MedlinePgn>1234-47</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-016-4307-6</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The management of peritonitis in critically ill patients is becoming increasingly complex due to their changing characteristics and the growing prevalence of multidrug-resistant (MDR) bacteria.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A multidisciplinary panel summarizes the latest advances in the therapeutic management of these critically ill patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Appendicitis, cholecystitis and bowel perforation represent the majority of all community-acquired infections, while most cases of healthcare-associated infections occur following suture leaks and/or bowel perforation. The micro-organisms involved include a spectrum of Gram-positive and Gram-negative bacteria, as well as anaerobes and fungi. Healthcare-associated infections are associated with an increased likelihood of MDR pathogens. The key elements for success are early and optimal source control and adequate surgery and appropriate antibiotic therapy. Drainage, debridement, abdominal cleansing, irrigation, and control of the source of contamination are the major steps to ensure source control. In life-threatening situations, a "damage control" approach is the safest way to gain time and achieve stability. The initial empirical antiinfective therapy should be prescribed rapidly and must target all of the micro-organisms likely to be involved, including MDR bacteria and fungi, on the basis of the suspected risk factors. Dosage adjustment needs to be based on pharmacokinetic parameters. Supportive care includes pain management, optimization of ventilation, haemodynamic and fluid monitoring, improvement of renal function, nutrition and anticoagulation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The majority of patients with peritonitis develop complications, including worsening of pre-existing organ dysfunction, surgical complications and healthcare-associated infections. The probability of postoperative complications must be taken into account in the decision-making process prior to surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Montravers</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>APHP, CHU Bichat-Claude Bernard, Département d'Anesthésie Réanimation, Université Denis Diderot, PRESS Sorbonne Cité, Paris, France. philippe.montravers@aphp.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blot</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimopoulos</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Critical Care, University Hospital Attikon, Medical School, University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckmann</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Thoracic Surgery, Klinikum Peine, Peine, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eggimann</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine and Burn Center, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guirao</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Endocrine and Head and Neck Surgery, Corporació Sanitaria del Parc Tauli, University Hospital, Sabadell, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paiva</LastName><ForeName>J A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Emergency and Intensive Care Department, Centro Hospitalar S. João EPE, Porto, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, University of Porto, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sganga</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Surgery, Catholic University of Sacred Heart, Policlinico A Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Waele</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Trauma. 1992 Jul;33(1):45-8; discussion 48-9</RefSource><PMID Version="1">1635105</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Intensive Care Med. 2014 Oct;40(10):1429-48</RefSource><PMID Version="1">24934813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Pharmacother. 2014 Feb;48(2):178-86</RefSource><PMID Version="1">24259653</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2010 Jan 15;50(2):133-64</RefSource><PMID Version="1">20034345</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Microbiol Infect. 2012 Dec;18 Suppl 7:19-37</RefSource><PMID Version="1">23137135</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Crit Care Med. 2009 May;37(5):1624-33</RefSource><PMID Version="1">19325481</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Surg. 2014 Jan;101(1):e51-64</RefSource><PMID Version="1">24338777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Trauma. 1997 Nov;43(5):852-5</RefSource><PMID Version="1">9390500</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Infect Dis. 2014 Jul 29;14:420</RefSource><PMID Version="1">25074742</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Clin Nutr. 2012 Sep;96(3):591-600</RefSource><PMID Version="1">22811443</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surgery. 2009 Oct;146(4):654-61; discussion 661-2</RefSource><PMID Version="1">19789024</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Intensive Care Med. 2014 Mar;40(3):427-30</RefSource><PMID Version="1">24435202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2011 Feb 1;52(3):285-92</RefSource><PMID Version="1">21217178</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infection. 2009 Dec;37(6):522-7</RefSource><PMID Version="1">19669089</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Crit Care. 2014 May 02;18(3):R87</RefSource><PMID Version="1">24886954</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Intensive Care Med. 2014 Feb;40(2):269-71</RefSource><PMID Version="1">24306079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Antimicrob Chemother. 2009 Apr;63(4):785-94</RefSource><PMID Version="1">19196742</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Antimicrob Chemother. 2014 Jan;69(1):190-9</RefSource><PMID Version="1">23883872</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Crit Care. 2011;15(5):R206</RefSource><PMID Version="1">21914174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Intensive Care Med. 2013 Feb;39(2):165-228</RefSource><PMID Version="1">23361625</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Respir Crit Care Med. 2013 Nov 1;188(9):1100-9</RefSource><PMID Version="1">23782027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Infect Dis. 2014 Apr;27(2):165-73</RefSource><PMID Version="1">24504134</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2015 Sep 26;386(10000):1269-77</RefSource><PMID Version="1">26209030</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2014 Mar 27;370(13):1227-36</RefSource><PMID Version="1">24670169</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2015 May 21;372(21):1996-2005</RefSource><PMID Version="1">25992746</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Chir Belg. 2006 Jan-Feb;106(1):2-21</RefSource><PMID Version="1">16612906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Rev Esp Quimioter. 2009 Sep;22(3):151-72</RefSource><PMID Version="1">19662549</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2015 Oct 6;314(13):1364-75</RefSource><PMID Version="1">26441181</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Infect Dis. 2008 Dec;21(6):610-9</RefSource><PMID Version="1">18978529</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chest. 2005 Oct;128(4):2688-95</RefSource><PMID Version="1">16236943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Pharmacol Sci. 2013;2013:194389</RefSource><PMID Version="1">24023540</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Intensive Care Med. 2013 Dec;39(12):2092-106</RefSource><PMID Version="1">24105327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surg Infect (Larchmt). 2015 Oct;16(5):626-35</RefSource><PMID Version="1">26114216</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Med Res. 2011 Mar 28;16(3):115-26</RefSource><PMID Version="1">21486724</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Microbiol Infect. 2006 Oct;12(10):980-5</RefSource><PMID Version="1">16961634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Intensive Care Med. 2014 Feb;40(2):202-10</RefSource><PMID Version="1">24306080</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Intensive Care Med. 2013 Dec;39(12):2226-30</RefSource><PMID Version="1">24154676</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2016 Feb 15;62(4):e1-50</RefSource><PMID Version="1">26679628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Emerg Surg. 2015 Aug 12;10:35</RefSource><PMID Version="1">26269709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Microbiol Infect. 2012 Dec;18 Suppl 7:9-18</RefSource><PMID Version="1">23137134</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Antimicrob Agents. 2013 Jan;41(1):52-6</RefSource><PMID Version="1">23228881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anaesth Crit Care Pain Med. 2015 Apr;34(2):117-30</RefSource><PMID Version="1">25922057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chest. 2016 Jun;149(6):1373-9</RefSource><PMID Version="1">26501514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2013 Jun;56(12):1765-73</RefSource><PMID Version="1">23463643</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cochrane Database Syst Rev. 2013 Feb 28;(2):CD004778</RefSource><PMID Version="1">23450555</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Obes Surg. 2012 Mar;22(3):465-71</RefSource><PMID Version="1">22249886</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surg Infect (Larchmt). 2004 Winter;5(4):365-73</RefSource><PMID Version="1">15744128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Emerg Surg. 2013 Jan 08;8(1):3</RefSource><PMID Version="1">23294512</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Invest Surg. 2009 Sep-Oct;22(5):362-7</RefSource><PMID Version="1">19842891</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pain. 2016 Feb;17 (2):131-57</RefSource><PMID Version="1">26827847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Crit Care. 2015 Mar 02;19:70</RefSource><PMID Version="1">25887649</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Medicine (Baltimore). 2015 Jul;94(30):e1224</RefSource><PMID Version="1">26222854</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Intensive Care Med. 2015 Jun;41(6):1114-7</RefSource><PMID Version="1">25672280</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surg Infect (Larchmt). 2012 Feb;13(1):38-42</RefSource><PMID Version="1">22217196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Can J Infect Dis Med Microbiol. 2010 Spring;21(1):11-37</RefSource><PMID Version="1">21358883</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Intensive Care Med. 2013 Jul;39(7):1190-206</RefSource><PMID Version="1">23673399</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 2016 Jan;263(1):117-22</RefSource><PMID Version="1">25489672</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Crit Care. 2015 Feb 27;19:60</RefSource><PMID Version="1">25849844</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Antimicrob Chemother. 2010 Feb;65(2):342-6</RefSource><PMID Version="1">20008043</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surg Infect (Larchmt). 2009 Feb;10(1):29-39</RefSource><PMID Version="1">19226202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Surg Clin North Am. 2012 Apr;92(2):243-57, viii</RefSource><PMID Version="1">22414411</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antimicrob Agents Chemother. 2013 Feb;57(2):708-15</RefSource><PMID Version="1">23147743</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chirurg. 2016 Jan;87(1):26-33</RefSource><PMID Version="1">26577434</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Intensive Care Med. 2012 Aug;38(8):1315-25</RefSource><PMID Version="1">22752333</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010538" MajorTopicYN="N">Peritonitis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fungal infection</Keyword><Keyword MajorTopicYN="N">Intra-abdominal hypertension</Keyword><Keyword MajorTopicYN="N">Multidrug-resistant bacteria</Keyword><Keyword MajorTopicYN="N">Peritonitis</Keyword><Keyword MajorTopicYN="N">Postoperative complications</Keyword><Keyword MajorTopicYN="N">Source control</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>01</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>03</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26984317</ArticleId><ArticleId IdType="doi">10.1007/s00134-016-4307-6</ArticleId><ArticleId IdType="pii">10.1007/s00134-016-4307-6</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B26 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001B26 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:26984317
|texte= Therapeutic management of peritonitis: a comprehensive guide for intensivists.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:26984317" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |